↑ トップへ ← 戻る

 Drug(薬物リスト) DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

51 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Avacopan   Avacopan   D11093   1件: C5AR1   3件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection   4件:
43,
44,
222,
223 
 2   Azathioprine   Azathioprine   D00238, D03033   -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162 
 3   Belimumab   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   8件:
11,
43,
44,
46,
49,
51,
53,
222 
 4   Belimumab 10 mg/kg   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   3件:
43,
46,
49 
 5   Blisibimod   Blisibimod   D10311   -   -   5件:
43,
44,
49,
63,
66 
 6   Ccx168   -   -   -   -   6件:
43,
44,
66,
109,
222,
223 
 7   Cellcept (mycophenolate mofetil)   Mycophenolate mofetil, Mycophenolic acid, cellcept, mycophenolate mofetil   D00752, D05094, D05095, D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   2件:
42,
43 
 8   Chimeric monoclonal antibody, igg4 subtype   -   -   -   -   2件:
43,
44 
 9   Corticosteroid   -   -   -   -   10件:
13,
42,
43,
44,
45,
66,
84,
96,
97,
222 
 10   Corticosteroid and azathioprine   Azathioprine   D00238, D03033   -   -   4件:
42,
43,
44,
45 
 11   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 12   Cyclophosphamide, azathioprine,prednisone,methylprednisolone   Azathioprine, Cyclophosphamide, Methylprednisolone, Ethanol   D00068, D00238, D00287, D00407, D00751, D00979, D02798, D03033, D04855, D05000, D05001, D05002, D06542, D07760   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   3件:
42,
43,
45 
 13   Freeze-dried sulfonated human normal immunoglobulin (ggs)   Immune Globulin Human   -   -   -   3件:
14,
43,
45 
 14   Galen® tablet   -   -   -   -   2件:
43,
44 
 15   Glucocorticoid (gc)   -   -   -   -   2件:
43,
44 
 16   Glucocorticoids   -   -   -   -   6件:
40,
41,
43,
44,
60,
62 
 17   Glucocorticoids (gc)   -   -   -   -   2件:
43,
44 
 18   Glucocorticoids - reduced dose   -   -   -   -   2件:
43,
44 
 19   Glucocorticoids - standard dose   -   -   -   -   2件:
43,
44 
 20   Human normal immunoglobulin   Immune Globulin Human   -   -   -   8件:
11,
13,
14,
43,
45,
50,
63,
65 
 21   Ifx-1   -   -   -   -   3件:
43,
44,
269 
 22   Infliximab   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   22件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
95,
96,
97,
98,
162,
164,
269,
271 
 23   Intravenous immunoglobulins (human immunoglobulins g)   -   -   -   -   1件:
43 
 24   Intravenous methyl prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
43 
 25   Mabthera®   -   -   -   -   6件:
13,
35,
43,
44,
46,
93 
 26   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   4件: Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 27   Methyl prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   3件:
43,
49,
96 
 28   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 29   Methylprednisolone (or other glucocorticoid)   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
43 
 30   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 31   Mycophenolate mofetil   Mycophenolic acid, Mycophenolate mofetil, mycophenolate mofetil   D00752, D05094, D05095, D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 32   Mycophenolate mofetil,methotrexate   Methotrexate, Mycophenolic acid, Mycophenolate mofetil, mycophenolate mofetil   D00142, D00752, D02115, D05094, D05095, D05096   4件: DHFR, DHFR2, IMPDH1, IMPDH2   6件: Antifolate resistance, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Purine metabolism   3件:
42,
43,
45 
 33   Naltrexone   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   11件:
6,
10,
13,
40,
41,
42,
43,
44,
45,
96,
97 
 34   Naltrexone hydrochloride   Triamcinolone, Naltrexone, naltrexone hydrochloride   D00385, D00983, D00984, D00985, D02095, D05113, D06216   4件: NR3C1, OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   7件:
10,
40,
41,
42,
43,
44,
45 
 35   Pednisone   -   -   -   -   2件:
43,
44 
 36   Placebo (physiological saline)   -   -   -   -   2件:
43,
45 
 37   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 38   Prednison acis® 20 mg   -   -   -   -   2件:
43,
44 
 39   Prednison acis® 5 mg   -   -   -   -   2件:
43,
44 
 40   Prednisone   Ethanol   D00068, D02798, D04855, D06542   -   -   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 41   Prednisone (and methylprednisolone)   Methylprednisolone, Ethanol   D00068, D00407, D00751, D00979, D02798, D04855, D05000, D05001, D05002, D06542   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
43 
 42   Prednisone tablets, usp   Ethanol   D00068, D02798, D04855, D06542   -   -   3件:
41,
43,
44 
 43   Prednisone, methylprednisolone,cyclophosphamides   Methylprednisolone, Ethanol   D00068, D00407, D00751, D00979, D02798, D04855, D05000, D05001, D05002, D06542   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   3件:
42,
43,
45 
 44   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 45   Rituximab (arm a)   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   2件:
43,
44 
 46   Rituximab (arm b)   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   2件:
43,
44 
 47   Rixathon 500mg   -   -   -   -   1件:
43 
 48   Ro0452294/v01   -   -   -   -   2件:
43,
44 
 49   Ro0452294/v02   -   -   -   -   3件:
35,
43,
44 
 50   Same   Ademetionine   D07128   -   -   15件:
6,
14,
22,
43,
44,
46,
47,
49,
50,
60,
84,
93,
96,
97,
172 
 51   Tocilizumab   Tocilizumab   D02596   1件: IL6R   11件: Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease (NAFLD), PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   16件:
2,
13,
40,
41,
43,
46,
50,
51,
53,
54,
55,
86,
107,
266,
271,
331 

先頭へ